Journal: The Journal of Clinical Investigation
Article Title: Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challenge
doi: 10.1172/JCI191440
Figure Lengend Snippet: PreGn binding antibodies were titrated and further assessed for their capacity to bind preGn-expressing cells. mAbs were serially titrated and allowed to incubate on preGn transiently expressing cells before washing and adding PE-conjugated secondary antibody. Secondary antibody was washed, and cells were resuspended for analysis on an iQue flow cytometer. Binding to transfected cells was observed relative to untransfected cells, and data are presented as mean values ± SD and represent duplicate values from each of 3 independent experiments. IC 50 values were calculated using a 4-parameter sigmoidal nonlinear fit in Prism software version 9 (GraphPad). CCHF-245 was used as a negative control.
Article Snippet: After 7 days, LCL supernatants were screened for the presence of CCHFV Gc-, Gn-, or GP38-recognizing antibodies using IbAr10200 strain M segment–transfected Expi293F cells on the Intellicyt iQue high-throughput flow cytometer as described below.
Techniques: Binding Assay, Expressing, Flow Cytometry, Transfection, Software, Negative Control